Clinical research and health tech companies Medidata and Cogstate are joining forces to speed up trials and improve outcomes measurement across diseases of the central nervous system, the partners ...
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s ...
Last week, FDA issued the final version of its 2023 revised draft guidance, “Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers,” which ...
On October 1, 2024, the US Food and Drug Administration (FDA) finalized its guidance on the use of electronic records in clinical investigations of drugs, devices, biologics, foods, tobacco products ...
Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...
Health tech company Flatiron Health, an independent affiliate of the Roche Group, is expanding the reach of its clinical data capture tool through a pact with NRG Oncology. NRG Oncology is a research ...
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company, was rated the pharmaceutical industry’s preferred provider of electronic data capture (EDC) solutions in a new report by Industry ...
The partnership will help develop standards for data transfer to eliminate manual steps used in clinical trials. Pharmaceutical giant Sanofi and health care technology company Flatiron Health, known ...
Oracle is introducing significant advancements to its Electronic Data Capture (EDC) solution, Oracle Clinical One Data Collection, offering new capabilities that enable seamless interoperability with ...
Based in St. Louis, TSCP invests in middle market businesses The private equity firm has managed more than $3.6 billion since being founded in 2000 Thompson Street Capital Partners has made an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback